PCRX — PACIRA BIOSCIENCES

Ownership history in CAXTON ASSOCIATES LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which CAXTON ASSOCIATES LP reported a position in PACIRA BIOSCIENCES (PCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2020 Q2)
Avg. % of fund
0.02%
First filed
2020 Q2
Last filed
2024 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 ADDED 34,200 +29,334 +602.8% 0.02% $515K $15.05
2020 Q2 INITIATED 4,866 — — 0.02% $255K $52.47
% of Fund (quarterly)    PCRX price (monthly, adj. close)

Other funds also holding PCRX

As of 2025 Q4 — sorted by position size

Doma Perpetual Capital Management LLC 20.21% Gagnon Advisors, LLC 3Y 7Y 4.29% GAGNON SECURITIES LLC 3Y 7Y 2.64% Bridge City Capital, LLC 3Y 7Y 2.17% Lion Point Capital, LP 3Y 7Y 1.81% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.79% Phocas Financial Corp. 3Y 7Y 0.5% EASTERLY INVESTMENT PARTNERS LLC 3Y 0.4% J. Goldman & Co LP 3Y 7Y 0.3% PDT Partners, LLC 3Y 7Y 0.28%
← Back to CAXTON ASSOCIATES LP Holdings